2021
Cerebral Venous Sinus Thrombosis in the U.S. Population, After Adenovirus-Based SARS-CoV-2 Vaccination, and After COVID-19
Bikdeli B, Chatterjee S, Arora S, Monreal M, Jimenez D, Krumholz HM, Goldhaber SZ, Elkind MSV, Piazza G. Cerebral Venous Sinus Thrombosis in the U.S. Population, After Adenovirus-Based SARS-CoV-2 Vaccination, and After COVID-19. Journal Of The American College Of Cardiology 2021, 78: 408-411. PMID: 34116145, PMCID: PMC8186447, DOI: 10.1016/j.jacc.2021.06.001.Peer-Reviewed Original ResearchMeSH KeywordsAdenovirus VaccinesCOVID-19COVID-19 VaccinesHospitalizationHumansPopulation SurveillanceSinus Thrombosis, IntracranialUnited StatesVaccination
2011
Real-world Imperative of Outcomes Research
Krumholz HM. Real-world Imperative of Outcomes Research. JAMA 2011, 306: 754-755. PMID: 21846857, DOI: 10.1001/jama.2011.1170.Peer-Reviewed Original Research
2005
Report of the National Heart, Lung, and Blood Institute Working Group on Outcomes Research in Cardiovascular Disease
Krumholz HM, Peterson ED, Ayanian JZ, Chin MH, DeBusk RF, Goldman L, Kiefe CI, Powe NR, Rumsfeld JS, Spertus JA, Weintraub WS. Report of the National Heart, Lung, and Blood Institute Working Group on Outcomes Research in Cardiovascular Disease. Circulation 2005, 111: 3158-3166. PMID: 15956152, DOI: 10.1161/circulationaha.105.536102.Peer-Reviewed Original ResearchConceptsCardiovascular diseaseNational HeartOutcomes researchBlood Institute Working GroupReal-world effectivenessNational surveillance projectPatient-centered careClinical decision makingWorking GroupBlood InstitutePatient outcomesClinical practiceSurveillance projectCost of interventionHealthcare deliveryLungDiseaseCareCV conditionsResearch investigatorsGroupBasic scienceResearch prioritiesHeart